MA
IMNN icon

Montag & Associates’s Imunon IMNN Stock Holding History

Montag & Associates’s Portfolio IMNN Stock Details IMNN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1
Closed – – 882
2021
Q3 		$0 Buy
+1
New +$208 ﹤0.01% 879

Other funds holding IMNN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Montag & Associates's IMNN Position: Q4 2021 in Review

Montag & Associates sold out of Imunon (IMNN) in Q4 2021, closing a stake of 1 share.

Montag & Associates first reported a position in IMNN in Q3 2021 and held it in 1 quarter. The position peaked at $0 in Q3 2021. 37 funds tracked by Wall St. Rank hold IMNN as of Q4 2021.

  • Montag & Associates reported no remaining Imunon position as of Q4 2021 after selling out during the quarter.
  • Montag & Associates sold 1 Imunon share in Q4 2021.
  • Montag & Associates first reported a position in Imunon in Q3 2021 and held it in 1 quarter.
  • Montag & Associates's Imunon position peaked at $0 in Q3 2021.
  • 37 funds tracked by Wall St. Rank held Imunon as of Q4 2021.

Based on Montag & Associates's 13F filing for Q4 2021, filed 9 Feb 2022.